Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 5.91
-9.91 %
$ 315 M
Market Cap
-7.88
P/E
INCOME STATEMENT
36.7 M
REVENUE
-35.6 M
OPERATING INCOME
-36.8 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Alpha Teknova, Inc.
| Revenue | 36.7 M |
| Cost Of Revenue | 26.4 M |
| Gross Profit | 10.3 M |
| Operating Expenses | 45.9 M |
| Operating Income | -35.6 M |
| Other Expenses | 1.22 M |
| Net Income | -36.8 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 36.7 | 41.4 | 36.9 | 31.3 | 20.1 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 26.4 | 23.9 | 19.3 | 13.5 | 11.5 |
| Gross Profit | 10.3 | 17.5 | 17.6 | 17.8 | 8.6 |
| OPERATING INCOME | |||||
| Operating Expenses | 45.9 | 46.3 | 29.6 | 13.1 | 10.4 |
| Selling, General and Administrative Expenses | 34.8 | 37.4 | 24.2 | 10.4 | 8.6 |
| Research and Development Expenses | 5.6 | 7.7 | 4.3 | 1.5 | 0.8 |
| Operating Income | (35.6) | (28.9) | (12.0) | 4.7 | (1.9) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0.8 | 0.2 | 0.6 | 0 | 0 |
| Total Other Income | (1.5) | 0.3 | (0.6) | 63 K | 2.8 |
| Pre-Tax Income | (37.1) | (49.4) | (12.6) | 4.7 | (1.8) |
| NET INCOME | |||||
| Tax Provision | (0.3) | (1.9) | (2.8) | 1.2 | (0.5) |
| Net Income | (36.8) | (47.5) | (9.8) | 3.6 | (1.3) |
| EPS | 1.16 | 1.69 | 0.35 | 0.14 | 0.05 |